Standard BioTools Inc. Shareholders' Equity
Standard BioTools Inc. (LAB) had Shareholders' Equity of $539.97 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $539.97M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $561.12M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $424.29M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $399.66M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $539.97M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $561.12M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $424.29M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $399.66M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $424.54M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $454.60M 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $471.72M 10-Q · filed 2026-08-05 | |
| 2024-09-30 | $489.33M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $510.26M 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $577.32M 10-Q · filed 2025-11-04 | |
| 2023-12-31 | -$148.05M 10-K · filed 2026-03-16 | |
| 2023-09-30 | -$131.72M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | -$113.39M 10-Q · filed 2024-11-06 | |
| 2023-03-31 | -$97.15M 10-Q · filed 2024-11-06 | |
| 2022-12-31 | -$81.47M 10-K · filed 2026-03-16 | |
| 2022-09-30 | -$62.75M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | -$37.45M 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $22.11M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $94.60M 10-K · filed 2025-03-11 | |
| 2021-09-30 | $99.34M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $109.45M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $122.94M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $139.05M 10-K · filed 2023-03-14 | |
| 2020-09-30 | $151.97M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $132.72M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $141.50M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $153.61M 10-K · filed 2022-03-08 | |
| 2019-09-30 | $162.60M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $172.64M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $182.25M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $72.12M 10-K · filed 2022-03-08 | |
| 2018-09-30 | $22.41M 10-Q · filed 2019-11-08 | $22.41M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $34.83M 10-Q · filed 2019-11-08 | $34.83M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $48.57M 10-Q · filed 2019-11-08 | |
| 2018-01-01 | $31.29M 10-K · filed 2019-03-18 | |
| 2017-12-31 | $30.93M 10-K · filed 2021-02-25 | |
| 2017-09-30 | $39.07M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $23.94M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $38.50M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $53.23M 10-K · filed 2020-02-27 | |
| 2016-09-30 | $67.97M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $84.26M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $98.98M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $114.90M 10-K · filed 2019-03-18 | |
| 2015-09-30 | $124.13M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $133.22M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $142.45M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $150.42M 10-K · filed 2018-03-08 | |
| 2014-09-30 | $154.56M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $161.83M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $167.43M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $96.41M 10-K · filed 2017-03-03 | |
| 2013-09-30 | $97.01M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $98.39M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $100.12M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $100.66M 10-K · filed 2016-02-29 | |
| 2012-09-30 | $102.66M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $48.92M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $51.90M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $56.90M 10-K · filed 2015-02-26 | |
| 2011-09-30 | $59.15M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $62.30M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | -$189.17M 10-K · filed 2014-03-12 | |
| 2009-12-31 | -$173.62M 10-K · filed 2013-03-12 | |
| 2008-12-27 | -$158.34M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |